EW Edwards Lifesciences Corporation Common Stock
$91,21
Kurs · Aug 18, 2026
Fundamentaldaten per Aug 4, 2026
52W-Spanne
$72–$96
79% of range
Analystenbewertung
BUY
40 analysts
Kursziel
$101
+11% upside
P/E (TTM)
56.6
ROE
10.6%
Nettogewinnmarge
17.7%
Über Edwards Lifesciences Corporation Common Stock Unternehmensübersicht von Wikipedia
Edwards Lifesciences mit Hauptsitz in Irvine, Kalifornien, und Edwards Lifesciences Services GmbH mit Sitz in Unterschleißheim ist ein Unternehmen auf dem Gebiet der Medizintechnik. Das Unternehmen ist im Aktienindex NYSE gelistet.
Mehr lesen
Edwards Lifesciences mit Hauptsitz in Irvine, Kalifornien, und Edwards Lifesciences Services GmbH mit Sitz in Unterschleißheim ist ein Unternehmen auf dem Gebiet der Medizintechnik. Das Unternehmen ist im Aktienindex NYSE gelistet.
Die Firma wurde im Jahr 1956 von Miles „Lowell“ Edwards und Albert Starr gegründet. Bei einem Umsatz von 5,38 Milliarden US-Dollar im Geschäftsjahr 2022 sind etwa 17 300 Mitarbeiter bei Edwards beschäftigt.
Bekannt ist das Unternehmen für seine Edwards SAPIEN-TAVI/TAVR-Produkte, diverse Herzklappen unterschiedlicher Größen, Herzklappen-Rekonstruktions-Produkte, Produkte für die Gefäßtherapie zusammen mit hämodynamischen Überwachungsgeräten zur Messung von Herz-Kreislauf-Leistung während der Operation und auf der Intensivstation, venöse Kanülen sowie dem Swan-Ganz-Katheter.
Geschichte
Im Jahr 1956 konstruierte Miles Lowell Edwards den Aufbau des ersten künstlichen Herzens. Schon seit seiner Jugend war er vom menschlichen Herz fasziniert. Mit einem Hintergrund in Hydraulik und Kraftstoffpumpenbetrieb hatte er vermutet, dass das menschliche Herz mechanisiert werden könne. Diese Idee stellte er Albert Starr, einem jungen Chirurgen an der Oregon Health & Science University, vor, der diese Idee jedoch als zu komplex empfand. Stattdessen ermutigte Starr Edwards, sich zunächst auf die Entwicklung einer künstlichen Herzklappe zu konzentrieren, für die eine unmittelbare Notwendigkeit bestand. Nach zwei Jahren wurde die erste Starr-Edwards Mitralklappe entworfen, entwickelt, getestet und erfolgreich bei einem Patienten implantiert. Diese Innovation hat das Unternehmen Edwards Laboratories, Santa Ana, hervorgebracht, welches sich nicht weit von der Edwards Lifesciences Unternehmenszentrale befindet.
Im Jahr 1966 wurde Edwards Laboratories von American Hospital Supply Corporation erworben und in American Edwards Laboratories umbenannt. Im Jahr 1985 wurde American Edwards von Baxter International erworben. Im Frühjahr 2000 wurde das Unternehmen als unabhängiges, börsennotiertes Unternehmen in einem Spin-off ausgegliedert und begann den Handel an der New York Stock Exchange unter dem Kürzel „EW“.
Auch heute noch ist Edwards als Marktführer auf dem Gebiet der Gewebeherzklappen und Reparaturprodukte modernster hämodynamischen Überwachung, die dazu beigetragen haben, mehr als zwei Millionen Patienten zu behandeln und weltweit zu verwalten.
Produkte
Edwards Produkte, Herzklappen aus biologischem Gewebe, welche unter Markennamen wie Carpentier-Edwards PERIMOUNT und Carpentier-Edwards PERIMOUNT MAGNA und auch Herzklappen-Rekonstruktions-Implantate verkauft werden – Herzklappen-Rekonstruktions-Implantate – sogenannte Annuloplastieringe – werden von Chirurgen verwendet, um die Herzklappe eines Patienten wieder in die native Form zu versetzen.
TAVI/TAVR
Die Edwards SAPIEN-Familie von Herzklappen werden über ein Verfahren namens Transkatheter-Aortenklappenersatz (TAVR) implantiert.
Dieses Verfahren ermöglicht die Platzierung und Implantierung zusammenlegbarer Herzklappen, die in einem Stent verankert sind und mit Hilfe eines Ballonkatheters oder durch „Gedächtnis-Metall“ wieder im Körper entfaltet werden können. Die Klappenprothesen gelangen über verschiedene Zugangswege in den Körper. Dabei werden Katheter eingesetzt und diese bis zum Herzen vorgeschoben. Etwa über eine Punktion in der Leiste (transfemoral), am Arm (transaxillär), zwischen den Rippen (transapikal) oder über die Vorderseite des Brustkorbs – durch ein kleines Loch in der Aorta (transaortal).
Weitere Produkte
Edwards fertigt darüber hinaus Produkte für die Gefäßtherapie zusammen mit hämodynamischen Überwachungsgeräten zur Messung von Herz-Kreislauf-Leistung während der Operation und auf der Intensivstation. Hämodynamische Überwachung ermöglicht die Messung der Blutzirkulation und der Herzfunktion, welche die Kliniker zur Messung verwenden, um auszuwerten, ob genügend Sauerstoff in die Organe und Gewebe geliefert wurde.
Unter weiteren Produkten von Edwards ist der Swan-Ganz-Katheter. Ursprünglich für Patienten mit akutem Herzinfarkt entwickelt, wird er nun in der Anästhesie und Intensivstation eingesetzt. Healthcare-Anbieter wenden diese Überwachung an, um über Änderungen oder Probleme des Gesundheitszustandes des Patienten informiert zu werden, diese zu erkennen und bei einer Behandlung Entscheidungen zu ermöglichen.
Um in der Herzchirurgie Verfahren durch kleinere Schnitte zu erleichtern, bietet Edwards auch eine Herzchirurgie Produktlinie für Weichgewebe-Retraktoren, mit venösen und arteriellen Kanülen, Aortenokklusionsvorrichtung, Entlüftung und koronare Sinus-Katheter, sowie wiederverwendbare Instrumente zur Durchführung von minimalinvasiven Herzklappenverfahren an.
Quelle: Wikipedia, CC BY-SA 4.0 · Auf Wikipedia ansehen ↗
EW Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$91.21
Marktkapitalisierung
$60.20B
P/E (TTM)
56.6
EPS (TTM)
$1.83
Umsatz (TTM)
$6.07B
Dividendenrendite
—
ROE
10.6%
Verschuldungsgrad
0.1
52W-Spanne
$72 – $96
EW Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Configure
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz & Nettoergebnis
$6.07B
2016-12-31
→
2025-12-31
EPS
$1.83
2016-12-31
→
2025-12-31
Freier Cashflow
$1.33B
2016-12-31
→
2025-12-31
Margen
17.7%
2016-12-31
→
2025-12-31
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
Kennzahl
5-Jahres-Trend
EW
Peer-Median
P/E (TTM)
56.6
26.3
P/S (TTM) (K/V (TTM))
9.9
4.4
P/B (K/B)
5.8
5.3
EV / EBITDA
39.8
—
Price / FCF (Kurs / FCF)
45.1
—
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
Kennzahl
5-Jahres-Trend
EW
Peer-Median
Gross Margin (Bruttogewinnmarge)
78.0%
63.1%
Operating Margin (Betriebsgewinnmarge)
20.8%
—
Net Profit Margin (Nettogewinnmarge)
17.7%
15.6%
ROA
8.0%
7.6%
ROE
10.6%
15.0%
ROIC
9.6%
—
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
Kennzahl
5-Jahres-Trend
EW
Peer-Median
Debt / Equity (Fremdkapital / Eigenkapital)
0.1
—
Current Ratio (Liquiditätsgrad)
3.7
1.7
Quick Ratio
2.7
—
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Kennzahl
5-Jahres-Trend
EW
Peer-Median
Revenue YoY (Umsatz YoY)
11.6%
—
Revenue CAGR 3Y (Umsatz CAGR 3J)
10.8%
—
Revenue CAGR 5Y (Umsatz CAGR 5J)
6.7%
—
EPS YoY (EPS VjV)
-73.7%
—
Net Income YoY (Nettogewinn YoY)
-74.3%
—
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
Kennzahl
5-Jahres-Trend
EW
Peer-Median
EW Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
KAUF
40 Analysten
- Starker Kauf 13 32,5%
- Kauf 17 42,5%
- Halten 10 25,0%
- Verkauf 0 0,0%
- Starker Verkauf 0 0,0%
12-Monats-Kursziel
26 Analysten · 2026-08-19
Median
$101.50
Jetzt
$91.21
Tief
$84.00
Hoch
$110.00
Median-Ziel
$101.50
+11,3%
Mittelwert-Ziel
$100.96
+10,7%
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
0.02%
| Zeitraum | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|
| 30. Juni 2026 | $0.78 | $0.76 | 0.02% |
| 31. März 2026 | $0.78 | $0.75 | 0.03% |
| 31. Dezember 2025 | $0.58 | $0.64 | -0.06% |
| 30. September 2025 | $0.67 | $0.61 | 0.06% |
| 30. Juni 2025 | $0.67 | $0.64 | 0.03% |
| 31. März 2025 | $0.64 | $0.61 | 0.03% |
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| EW | $49.50B | 46.6 | 11.6% | 17.7% | 10.6% | 78.0% |
| ABT | $250.18B | 33.7 | 5.7% | 14.7% | 13.1% | — |
| ISRG | $201.11B | 72.0 | 20.5% | 28.4% | 16.7% | 66.0% |
| SYK | $134.44B | 41.8 | 11.2% | 12.9% | 15.1% | 64.0% |
| BSX | — | 49.1 | 19.9% | 14.4% | 12.6% | 69.0% |
| BDX | — | 25.3 | 8.2% | 7.7% | 6.5% | — |
| IDXX | $53.93B | 51.7 | 10.4% | 24.6% | 69.2% | 61.8% |
| DXCM | $25.54B | 31.8 | 15.6% | 17.9% | 31.4% | 60.1% |
| GEHC | — | 18.0 | 4.8% | 10.1% | 22.1% | 40.0% |
| RMD | $28.11B | 18.7 | 9.8% | 26.9% | 23.6% | 61.1% |
| ZBH | $28.66B | 25.3 | 7.2% | 8.6% | 5.6% | — |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung 17
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $6.07B | $5.44B | $5.01B | $4.46B | $5.23B | $4.39B | $4.35B | $3.72B | $3.44B | $2.96B | $2.49B | $2.32B | |
| Cost of Revenue | $1.33B | $1.12B | $978M | $724M | $1.25B | $1.08B | $1.11B | $939M | $875M | $797M | $617M | $626M | |
| Gross Profit | $4.73B | $4.32B | $4.03B | $3.74B | $3.98B | $3.31B | $3.23B | $2.78B | $2.56B | $2.17B | $1.88B | $1.70B | |
| R&D Expense | $1.08B | $1.05B | $963M | $844M | $903M | $761M | $753M | $622M | $553M | $442M | $383M | $346M | |
| SG&A Expense | $2.09B | $1.79B | $1.58B | $1.36B | $1.49B | $1.23B | $1.24B | $1.09B | $991M | $905M | $851M | $858M | |
| Operating Income | $1.26B | $1.38B | $1.31B | $1.50B | $1.69B | $898M | $1.15B | $748M | $1.09B | $751M | · | · | |
| Interest Expense | · | · | $18M | $19M | $18M | $16M | $21M | $30M | $23M | $19M | $17M | $17M | |
| Interest Income | $169M | $120M | $67M | $36M | $17M | $23M | $32M | $32M | $20M | $11M | $8M | $6M | |
| Other Non-op | $7M | $69M | $14M | $5M | $13M | $12M | $8M | $4M | $-1M | $-5M | $-4M | $-8M | |
| Pretax Income | $1.27B | $1.55B | $1.37B | $1.52B | $1.70B | $917M | $1.17B | $761M | $1.03B | $738M | $622M | $1.14B | |
| Income Tax | $217M | $152M | $152M | $196M | $199M | $93M | $120M | $39M | $451M | $168M | $128M | $333M | |
| Net Income | $1.07B | $4.17B | $1.40B | $1.52B | $1.50B | · | · | · | · | · | · | · | |
| EPS (Basic) | $1.84 | $6.98 | $2.31 | $2.46 | $2.41 | $1.32 | $1.68 | $1.15 | $2.77 | $2.67 | $2.30 | $3.81 | |
| EPS (Diluted) | $1.83 | $6.97 | $2.30 | $2.44 | $2.38 | $1.30 | $1.64 | $1.13 | $2.70 | $2.61 | $2.25 | $3.74 | |
| Shares (Basic) | 584,800,000 | 597,700,000 | 606,700,000 | 619,000,000 | 623,300,000 | 622,600,000 | 624,800,000 | 627,600,000 | 210,900,000 | 213,000,000 | 215,500,000 | 213,000,000 | |
| Shares (Diluted) | 585,800,000 | 599,300,000 | 609,400,000 | 624,200,000 | 631,200,000 | 631,900,000 | 636,700,000 | 640,900,000 | 215,900,000 | 217,800,000 | 220,300,000 | 217,000,000 | |
| EBITDA | $1.42B | $1.53B | $1.68B | $1.89B | $1.83B | $1.00B | $1.24B | $826M | $82M | $71M | $66M | $69M |
Bilanz 29
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $2.94B | $3.05B | $1.13B | $769M | $863M | $1.18B | $1.18B | $714M | $818M | $930M | $718M | $654M | |
| Short-term Investments | $1.29B | $931M | $500M | $446M | $604M | $219M | $338M | $242M | $519M | $341M | $506M | $785M | |
| Receivables | $660M | $609M | $772M | $643M | $582M | $515M | $544M | $457M | $439M | $366M | $315M | $288M | |
| Inventory | $1.13B | $1.09B | $904M | $876M | $727M | $802M | $641M | $607M | $555M | $397M | $340M | $297M | |
| Prepaid Expense | $135M | $121M | $129M | $110M | $85M | $75M | $59M | $54M | $61M | $46M | $45M | $49M | |
| Other Current Assets | $339M | $348M | $225M | $196M | $237M | $208M | $168M | $132M | $117M | $112M | $66M | $122M | |
| Current Assets | $6.74B | $6.29B | $4.04B | $3.10B | $3.18B | $3.09B | $2.98B | $2.29B | $2.55B | $2.24B | $2.05B | $2.23B | |
| PP&E (Net) | $1.81B | $1.69B | $1.59B | $1.63B | $1.55B | $1.40B | $1.06B | $868M | $680M | $580M | $482M | $443M | |
| PP&E (Gross) | $2.66B | $2.48B | $2.29B | $2.38B | $2.20B | $1.99B | $1.57B | $1.32B | $1.09B | $961M | $854M | $808M | |
| Accum. Depreciation | $850M | $794M | $699M | $750M | $655M | $598M | $512M | $455M | $412M | $381M | $372M | $365M | |
| Goodwill | $1.77B | $1.78B | $1.15B | $1.06B | $1.17B | $1.17B | $1.17B | $1.11B | $1.13B | $626M | $628M | $376M | |
| Intangibles | $1.13B | $1.18B | $399M | $285M | $324M | $331M | $336M | $343M | $468M | $205M | $205M | $23M | |
| Other Non-current Assets | $730M | $722M | $463M | $299M | $111M | $120M | $102M | $34M | $109M | $123M | $132M | $49M | |
| Total Assets | $13.70B | $13.06B | $9.36B | $8.29B | $8.50B | $7.24B | $6.49B | $5.32B | $5.67B | $4.51B | $4.06B | $3.52B | |
| Accounts Payable | $228M | $197M | $187M | $202M | $204M | $196M | $180M | $134M | $117M | $97M | $64M | $58M | |
| Current Liabilities | $1.81B | $1.51B | $1.20B | $1.02B | $1.03B | $894M | $902M | $877M | $1.42B | $532M | $476M | $426M | |
| Capital Leases | $83M | $79M | $65M | $70M | $69M | $73M | $59M | · | · | · | · | · | |
| Deferred Tax | · | · | · | · | · | · | $37M | · | · | · | · | · | |
| Other Non-current Liabilities | $362M | $373M | $251M | $218M | $267M | $252M | $203M | $150M | $147M | $115M | $285M | $113M | |
| Total Liabilities | $3.36B | $2.99B | $2.64B | $2.49B | $2.67B | $2.66B | · | · | · | · | · | · | |
| Long-term Debt | · | · | · | · | · | · | · | $594M | $1.04B | $822M | · | · | |
| Total Debt | $598M | $598M | $597M | $596M | $596M | $595M | $594M | $594M | $1.04B | $822M | $600M | $598M | |
| Common Stock | $659M | $655M | $650M | $646M | $642M | $636M | $218M | $215M | $212M | $243M | $239M | $129M | |
| Retained Earnings | $14.24B | $13.17B | $8.99B | $7.59B | $6.07B | $4.57B | $3.74B | $2.69B | $1.96B | $3.91B | $3.34B | $2.84B | |
| Treasury Stock | $7.09B | $6.19B | $5.02B | $4.14B | $2.42B | $1.90B | $1.28B | $1.02B | $252M | $2.50B | $1.84B | $1.56B | |
| AOCI | $-238M | $-244M | $-243M | $-255M | $-158M | $-161M | $-156M | $-138M | $-133M | $-198M | $-183M | $-101M | |
| Stockholders' Equity | $10.34B | $10.00B | $6.65B | $5.81B | $5.84B | $4.57B | $4.15B | $3.14B | $2.96B | $2.62B | $2.50B | $2.19B | |
| Liabilities + Equity | $13.70B | $13.06B | $9.36B | $8.29B | $8.50B | $7.24B | $6.49B | $5.32B | $5.67B | $4.51B | $4.06B | $3.52B | |
| Shares Outstanding | 580,700,000 | 654,800,000 | 650,500,000 | 646,300,000 | 642,000,000 | 636,400,000 | 218,100,000 | 207,700,000 | 209,700,000 | 211,600,000 | 215,400,000 | 107,800,000 |
Cashflow 18
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $157M | $155M | $145M | $140M | $135M | $107M | $89M | $77M | $82M | $71M | $66M | $69M | |
| Stock-based Comp | $158M | $162M | $139M | $127M | $109M | $93M | $81M | $71M | $62M | $57M | $50M | $48M | |
| Deferred Tax | $-66M | $-163M | $-242M | $-262M | $-44M | $-52M | $10M | $-21M | $27M | $-24M | $-16M | $-67M | |
| Amort. of Intangibles | $8M | $6M | $2M | $2M | $8M | $5M | $5M | $2M | $8M | $8M | $7M | $8M | |
| Restructuring | $13M | $33M | · | · | · | · | · | · | · | · | $0 | $0 | |
| Other Non-cash | $273M | $-3.79B | $-529M | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $1.60B | $542M | $896M | $1.22B | $1.73B | $1.05B | $1.18B | $927M | $1.00B | $704M | $550M | $1.02B | |
| CapEx | $260M | $252M | $253M | $245M | $326M | $407M | $254M | $239M | $168M | $176M | $103M | $83M | |
| Investing Cash Flow | $-713M | $2.31B | $174M | $252M | $-1.72B | $-531M | $-596M | $77M | $-647M | $-212M | $-316M | · | |
| Debt Issued | · | · | $0 | $0 | $5M | $16M | $19M | $688M | $995M | $254M | $31M | $226M | |
| Net Debt Issued | · | · | $0 | $0 | $5M | $16M | $19M | $688M | $995M | $254M | $31M | $226M | |
| Stock Repurchased | $893M | $1.16B | $880M | $1.73B | $513M | $625M | $263M | $796M | $763M | $662M | $280M | $301M | |
| Net Stock Activity | $-893M | $-1.16B | $-880M | $-1.73B | $-513M | $-625M | $-263M | $-796M | $-763M | $-662M | $-280M | $-301M | |
| Financing Cash Flow | $-957M | $-983M | $-711M | $-1.58B | $-356M | $-487M | $-116M | $-1.10B | $-473M | $-268M | $-159M | · | |
| Net Change in Cash | $-119M | $1.91B | $375M | $-95M | $-333M | $16M | $468M | $-104M | $-112M | $212M | $65M | $233M | |
| Taxes Paid | $490M | $1.20B | $470M | · | · | · | · | · | · | · | · | $275M | |
| Free Cash Flow | $1.33B | $290M | $643M | $974M | $1.41B | $647M | $925M | $688M | $833M | $528M | $447M | $939M | |
| Levered FCF | · | · | $627M | $957M | $1.39B | $633M | $906M | $660M | $820M | $513M | $433M | $927M |
Rentabilität 8
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 78.0% | 79.5% | 77.0% | 79.9% | 76.1% | 75.4% | 74.4% | 74.8% | 74.5% | 73.1% | 75.2% | 73.1% | |
| Operating Margin | 20.8% | 25.4% | 25.6% | 32.5% | 32.3% | 20.5% | 26.4% | 20.1% | · | · | · | · | |
| Net Margin | 17.7% | 76.8% | 23.4% | · | · | · | · | · | · | · | · | · | |
| Pretax Margin | 21.0% | 28.5% | 26.6% | 32.8% | 32.5% | 20.9% | 26.8% | 20.4% | 30.1% | 24.9% | 25.0% | 49.2% | |
| EBITDA Margin | 23.4% | 28.2% | 28.0% | 35.1% | 34.9% | 22.9% | 28.4% | 22.2% | 2.4% | 2.4% | 2.6% | 2.9% | |
| ROA | 8.0% | 37.2% | 15.9% | · | · | · | · | · | · | · | · | · | |
| ROE | 10.6% | 50.1% | 22.5% | · | · | · | · | · | · | · | · | · | |
| ROIC | 9.6% | 11.7% | 18.5% | 23.5% | 23.2% | 15.6% | 21.7% | 19.0% | · | · | · | · |
Liquidität & Solvenz 5
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.7 | 4.2 | 3.4 | 3.0 | 3.1 | 3.5 | 3.3 | 2.6 | 1.8 | 4.2 | 4.3 | 5.3 | |
| Quick Ratio | 2.7 | 3.0 | 2.0 | 1.8 | 2.0 | 2.1 | 2.3 | 1.6 | 1.3 | 3.1 | 3.2 | 4.0 | |
| Debt / Equity | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | 0.4 | 0.3 | 0.2 | 0.3 | |
| LT Debt / Equity | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | 0.1 | 0.3 | 0.2 | 0.3 | |
| Interest Coverage | · | · | 87.2 | 91.1 | 91.9 | 56.8 | 55.4 | 25.0 | · | · | · | · |
Effizienz 3
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.5 | 0.5 | 0.7 | 0.6 | 0.7 | 0.6 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | |
| Inventory Turnover | 1.2 | 1.1 | 1.4 | 1.3 | 1.6 | 1.5 | 1.8 | 1.6 | 1.8 | 2.2 | 1.9 | 2.1 | |
| Receivables Turnover | 9.6 | 7.9 | 8.5 | 8.8 | 9.5 | 8.3 | 8.7 | 8.3 | 8.7 | 8.7 | 8.3 | 7.9 |
Wachstumsraten 8
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 11.6% | 8.6% | 12.2% | -14.7% | 19.3% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 10.8% | 1.3% | 4.5% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 6.7% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | -73.7% | 203.0% | -5.7% | 2.5% | 83.1% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | -9.1% | 43.1% | 20.9% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 7.1% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | -74.3% | 197.7% | -7.8% | 1.2% | · | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | -11.0% | 40.6% | · | · | · | · | · | · | · | · | · | · |
Bewertung (TTM) 14
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $6.07B | $5.44B | $5.01B | $4.46B | $5.23B | $4.39B | $4.35B | $3.72B | $3.44B | $2.96B | $2.49B | $2.32B | |
| Net Income TTM | $1.07B | $4.17B | $1.40B | $1.52B | $1.50B | $235M | $235M | $235M | $235M | $235M | $235M | $235M | |
| Market Cap | $49.50B | $43.57B | $45.83B | $45.39B | $80.85B | $56.95B | $16.26B | $10.60B | $7.88B | $6.61B | $5.67B | $2.29B | |
| Enterprise Value | $45.88B | $40.20B | $44.79B | $44.77B | $79.98B | $56.15B | $15.34B | $10.24B | $7.58B | $6.16B | $5.05B | $1.45B | |
| P/E | 46.6 | 10.6 | 33.2 | 30.6 | 54.4 | 70.2 | 47.4 | 45.2 | 13.9 | 12.0 | 11.7 | 5.7 | |
| P/S | 8.2 | 8.0 | 9.1 | 10.2 | 15.5 | 13.0 | 3.7 | 2.8 | 2.3 | 2.2 | 2.3 | 1.0 | |
| P/B | 4.8 | 4.4 | 6.9 | 7.8 | 13.9 | 12.5 | 3.9 | 3.4 | 2.7 | 2.5 | 2.3 | 1.0 | |
| P / Tangible Book | 6.7 | 6.2 | 9.0 | 10.2 | 18.6 | 18.6 | · | · | · | · | · | · | |
| P / Cash Flow | 31.0 | 80.4 | 51.2 | 37.3 | 46.7 | 54.0 | 13.8 | 11.4 | 7.9 | 9.4 | 10.3 | 2.2 | |
| P / FCF | 37.1 | 150.3 | 71.3 | 46.6 | 57.5 | 88.0 | 17.6 | 15.4 | 9.5 | 12.5 | 12.7 | 2.4 | |
| EV / EBITDA | 32.3 | 26.2 | 26.7 | 23.7 | 43.8 | 55.9 | 12.4 | 12.4 | 92.5 | 86.5 | 76.7 | 21.1 | |
| EV / FCF | 34.4 | 138.7 | 69.7 | 46.0 | 56.9 | 86.7 | 16.6 | 14.9 | 9.1 | 11.7 | 11.3 | 1.5 | |
| EV / Revenue | 7.6 | 7.4 | 8.9 | 10.0 | 15.3 | 12.8 | 3.5 | 2.8 | 2.2 | 2.1 | 2.0 | 0.6 | |
| Earnings Yield | 2.1% | 9.4% | 3.0% | 3.3% | 1.8% | 1.4% | 2.1% | 2.2% | 7.2% | 8.4% | 8.6% | 17.6% |
Gewinn- und Verlustrechnung 16
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.74B | $1.65B | $1.57B | $1.55B | $1.53B | $1.41B | $1.39B | $1.35B | $1.37B | $1.33B | $1.01B | $1.24B | $1.28B | $1.22B | $430M | $1.32B | |
| Cost of Revenue | $392M | $363M | $343M | $345M | $344M | $302M | $292M | $263M | $276M | $287M | $141M | $251M | $257M | $330M | $-99M | $254M | |
| Gross Profit | $1.35B | $1.29B | $1.23B | $1.21B | $1.19B | $1.11B | $1.09B | $1.09B | $1.09B | $1.04B | $870M | $993M | $1.03B | $992M | $529M | $1.07B | |
| R&D Expense | $279M | $263M | $268M | $281M | $276M | $255M | $271M | $253M | $272M | $257M | $215M | $243M | $244M | $261M | $131M | $234M | |
| SG&A Expense | $561M | $522M | $603M | $515M | $502M | $466M | $492M | $421M | $448M | $428M | $354M | $382M | $410M | $436M | $201M | $377M | |
| Operating Income | $513M | $478M | $151M | $307M | $411M | $395M | $313M | $351M | $366M | $349M | $291M | $366M | $264M | $388M | $198M | $402M | |
| Interest Income | $30M | $34M | · | · | $37M | $36M | · | · | · | · | · | · | · | · | · | · | |
| Other Non-op | $17M | $72M | $3M | $3M | $-1M | $3M | $33M | $28M | $2M | $6M | $3M | $7M | $2M | $2M | $6M | $-2M | |
| Pretax Income | $520M | $459M | $90M | $348M | $400M | $434M | $390M | $403M | $384M | $371M | $311M | $388M | $275M | $399M | $211M | $407M | |
| Income Tax | $278M | $78M | $26M | $56M | $64M | $70M | $45M | $41M | $20M | $46M | $21M | $53M | $21M | $58M | $11M | $64M | |
| Net Income | $242M | $381M | $91M | $291M | $333M | $358M | $386M | $3.07B | $366M | $352M | $370M | $385M | $307M | $340M | $398M | $344M | |
| EPS (Basic) | $0.42 | $0.66 | $0.16 | $0.50 | $0.57 | $0.61 | $0.65 | $5.14 | $0.61 | $0.58 | $0.61 | $0.63 | $0.51 | $0.56 | $0.66 | $0.55 | |
| EPS (Diluted) | $0.42 | $0.66 | $0.16 | $0.50 | $0.56 | $0.61 | $0.65 | $5.13 | $0.61 | $0.58 | $0.61 | $0.63 | $0.50 | $0.56 | $0.65 | $0.55 | |
| Shares (Basic) | 576,400,000 | 579,200,000 | -1,173,800,000 | 584,700,000 | 587,000,000 | 586,900,000 | -1,203,200,000 | 597,200,000 | 602,100,000 | 601,600,000 | -1,214,700,000 | 607,000,000 | 606,900,000 | 607,500,000 | -1,243,800,000 | 619,800,000 | |
| Shares (Diluted) | 577,600,000 | 580,700,000 | -1,175,600,000 | 585,700,000 | 587,900,000 | 587,800,000 | -1,207,200,000 | 598,100,000 | 604,300,000 | 604,100,000 | -1,221,300,000 | 609,500,000 | 610,300,000 | 610,900,000 | -1,256,400,000 | 624,500,000 | |
| EBITDA | $513M | $518M | · | $307M | $411M | $431M | · | $351M | $369M | $426M | · | $418M | $327M | $424M | · | $402M |
Bilanz 27
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $2.91B | $2.45B | $2.94B | $2.69B | $3.27B | $3.14B | $3.05B | $3.68B | $1.64B | $1.22B | · | $1.41B | $1.04B | $872M | · | $1.25B | |
| Short-term Investments | $1.35B | $1.23B | $1.29B | $1.16B | $789M | $758M | $931M | $770M | $345M | $473M | · | $454M | $467M | $382M | · | $491M | |
| Receivables | $770M | $776M | $660M | $693M | $697M | $669M | $609M | $716M | $778M | $818M | · | $740M | $754M | $718M | · | $618M | |
| Inventory | $1.13B | $1.12B | $1.13B | $1.14B | $1.14B | $1.11B | $1.09B | $1.10B | $1.02B | $1.21B | · | $1.03B | $980M | $914M | · | $758M | |
| Prepaid Expense | $119M | $136M | $135M | $125M | $110M | $111M | $121M | $115M | $110M | $138M | · | $133M | $123M | $119M | · | $88M | |
| Other Current Assets | $360M | $330M | $339M | $323M | $314M | $304M | $348M | $231M | $252M | $251M | · | $236M | $217M | $190M | · | $268M | |
| Current Assets | $6.82B | $6.23B | $6.74B | $6.36B | $6.58B | $6.21B | $6.29B | $6.73B | $4.52B | $4.17B | · | $4.07B | $3.65B | $3.26B | · | $3.51B | |
| PP&E (Net) | $1.84B | $1.82B | $1.81B | $1.74B | $1.73B | $1.70B | $1.69B | $1.68B | $1.64B | $1.77B | · | $1.68B | $1.66B | $1.65B | · | $1.57B | |
| PP&E (Gross) | · | · | $2.66B | · | · | · | $2.48B | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $850M | · | · | · | $794M | · | · | · | · | · | · | · | · | · | |
| Goodwill | $1.95B | $1.82B | $1.77B | $1.77B | $1.78B | $1.78B | $1.78B | $1.61B | $1.15B | $1.25B | $1.15B | $1.30B | $1.30B | $1.31B | $1.06B | $1.16B | |
| Intangibles | $1.38B | $1.23B | $1.13B | $1.13B | $1.17B | $1.17B | $1.18B | $956M | $417M | $447M | · | $430M | $431M | $447M | · | $266M | |
| Other Non-current Assets | $616M | $739M | $730M | $785M | $743M | $743M | $722M | $684M | $790M | $768M | · | $447M | $412M | $294M | · | $316M | |
| Total Assets | $13.87B | $13.32B | $13.70B | $13.27B | $13.49B | $13.02B | $13.06B | $12.97B | $10.10B | $9.74B | · | $9.37B | $9.00B | $8.65B | · | $8.64B | |
| Accounts Payable | $210M | $181M | $228M | $165M | $162M | $172M | $197M | $173M | $186M | $212M | · | $191M | $193M | $181M | · | $155M | |
| Current Liabilities | $1.51B | $1.41B | $1.81B | $1.59B | $1.40B | $1.39B | $1.51B | $1.94B | $1.22B | $1.11B | · | $1.24B | $1.16B | $1.08B | · | $918M | |
| Capital Leases | $82M | $80M | $83M | $75M | $79M | $78M | $79M | $85M | $74M | $77M | · | $70M | $64M | $66M | · | $67M | |
| Other Non-current Liabilities | $382M | $351M | $362M | $363M | $379M | $358M | $373M | $323M | $257M | $266M | · | $240M | $243M | $260M | · | $221M | |
| Total Liabilities | $3.14B | $2.99B | $3.36B | $3.07B | $2.88B | $2.83B | $2.99B | $3.36B | $2.59B | $2.55B | · | $2.64B | $2.56B | $2.59B | · | $2.42B | |
| Total Debt | $599M | $598M | · | $598M | $598M | $598M | · | $598M | $597M | $597M | · | $597M | $597M | $596M | · | $596M | |
| Common Stock | $662M | $660M | $659M | $658M | $658M | $656M | $655M | $654M | $654M | $652M | · | $650M | $649M | $647M | · | $646M | |
| Retained Earnings | $14.86B | $14.62B | $14.24B | $14.15B | $13.86B | $13.53B | $13.17B | $12.78B | $9.71B | $9.34B | · | $8.62B | $8.24B | $7.93B | · | $7.19B | |
| Treasury Stock | $7.67B | $7.51B | $7.09B | $7.05B | $6.46B | $6.45B | $6.19B | $6.09B | $5.18B | $5.02B | · | $4.58B | $4.40B | $4.39B | · | $3.28B | |
| AOCI | $-215M | $-221M | $-238M | $-250M | $-264M | $-254M | $-244M | $-252M | $-220M | $-233M | · | $-250M | $-256M | $-255M | · | $-256M | |
| Stockholders' Equity | $10.62B | $10.33B | $10.34B | $10.21B | $10.55B | $10.13B | $10.00B | $9.55B | $7.44B | $7.12B | · | $6.66B | $6.38B | $5.98B | · | $6.22B | |
| Liabilities + Equity | $13.87B | $13.32B | $13.70B | $13.27B | $13.49B | $13.02B | $13.06B | $12.97B | $10.10B | $9.74B | · | $9.37B | $9.00B | $8.65B | · | $8.64B | |
| Shares Outstanding | 576,600,000 | 577,000,000 | 580,700,000 | 580,700,000 | 587,900,000 | 586,200,000 | 588,600,000 | 589,800,000 | 602,300,000 | 602,400,000 | 650,500,000 | 606,500,000 | 607,900,000 | 606,000,000 | 646,300,000 | 619,400,000 |
Cashflow 13
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $43M | $41M | $43M | $39M | $38M | $37M | $43M | $34M | $40M | $38M | $37M | $37M | $36M | $35M | $35M | $35M | |
| Stock-based Comp | $42M | $45M | $39M | $41M | $38M | $40M | $32M | $42M | $44M | $45M | $30M | $33M | $37M | $39M | $28M | $30M | |
| Restructuring | · | · | $5M | $100.0K | · | · | $0 | $33M | · | · | · | $0 | · | · | · | · | |
| Other Non-cash | · | $-423M | · | · | · | $-154M | · | · | · | $-488M | · | · | · | · | · | · | |
| Operating Cash Flow | $652M | $44M | $451M | $574M | $290M | $280M | $-128M | $352M | $372M | $-54M | $137M | $412M | $34M | $314M | $283M | $310M | |
| CapEx | $67M | $65M | $97M | $58M | $49M | $56M | $50M | $52M | $85M | $65M | $88M | $55M | $48M | $62M | $69M | $60M | |
| Investing Cash Flow | $-193M | $-93M | $-198M | $-428M | $-172M | $85M | $-577M | $2.70B | $125M | $63M | $14M | $89M | $70M | $500.0K | $95M | $-202M | |
| Debt Issued | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | |
| Stock Repurchased | $153M | $422M | $41M | $589M | $6M | $259M | $100M | $901M | $158M | $200.0K | $448M | $174M | $8M | $249M | $866M | $100M | |
| Net Stock Activity | · | $-422M | · | · | · | $-259M | · | · | · | $-200.0K | · | · | · | $-249M | · | · | |
| Financing Cash Flow | $-300.0K | $-451M | $-11M | $-740M | $53M | $-258M | $29M | $-977M | $-97M | $62M | $-413M | $-143M | $52M | $-207M | $-838M | $-70M | |
| Net Change in Cash | $462M | $-492M | $245M | $-595M | $141M | $90M | $-625M | $2.03B | $429M | $81M | $-266M | $366M | $171M | $104M | $-479M | $49M | |
| Free Cash Flow | · | $-21M | · | · | · | $224M | · | · | · | $-119M | · | · | · | $253M | · | · |
Rentabilität 8
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 77.5% | 78.0% | · | 77.8% | 77.5% | 78.6% | · | 80.6% | 79.4% | 75.9% | · | 76.3% | 77.6% | 77.4% | · | 80.8% | |
| Operating Margin | 29.5% | 29.0% | · | 19.8% | 26.8% | 28.0% | · | 25.9% | 26.6% | 24.2% | · | 28.2% | 21.4% | 26.6% | · | 30.5% | |
| Net Margin | 13.9% | 23.1% | · | 18.7% | 21.8% | 25.3% | · | 226.7% | 26.4% | 22.0% | · | 26.0% | 20.1% | · | · | · | |
| Pretax Margin | 29.9% | 27.8% | · | 22.4% | 26.1% | 30.7% | · | 29.7% | 27.9% | 25.6% | · | 29.7% | 22.1% | 27.3% | · | 30.9% | |
| EBITDA Margin | 29.5% | 31.4% | · | 19.8% | 26.8% | 30.5% | · | 25.9% | 26.6% | 26.7% | · | 28.2% | 21.4% | 29.0% | · | 30.5% | |
| ROA | 1.8% | 2.9% | · | 2.2% | 2.8% | 3.1% | · | 27.5% | 3.8% | 3.8% | · | 4.3% | 3.5% | · | · | · | |
| ROE | 2.3% | 3.7% | · | 2.9% | 3.7% | 4.2% | · | 37.9% | 5.3% | 5.4% | · | 6.0% | 5.0% | · | · | · | |
| ROIC | 2.1% | 3.6% | · | 2.4% | 3.1% | 3.1% | · | 3.1% | 4.3% | 4.3% | · | 5.0% | 4.2% | 5.1% | · | 5.0% |
Liquidität & Solvenz 4
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.5 | 4.4 | · | 4.0 | 4.7 | 4.5 | · | 3.5 | 3.7 | 3.8 | · | 3.3 | 3.2 | 3.0 | · | 3.8 | |
| Quick Ratio | 3.3 | 3.2 | · | 2.9 | 3.4 | 3.3 | · | 2.7 | 2.3 | 2.3 | · | 2.1 | 2.0 | 1.8 | · | 2.6 | |
| Debt / Equity | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| LT Debt / Equity | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 |
Effizienz 3
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | |
| Inventory Turnover | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.2 | 0.3 | 0.4 | · | 0.4 | 0.4 | 0.4 | · | 0.3 | |
| Receivables Turnover | 2.4 | 2.3 | · | 2.2 | 2.1 | 1.9 | · | 1.9 | 1.8 | 2.1 | · | 2.2 | 2.2 | 2.2 | · | 2.2 |
Bewertung (TTM) 14
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $6.47B | $6.15B | · | $5.88B | $5.69B | $5.52B | · | $5.32B | $5.21B | $5.12B | · | $5.06B | $5.19B | $5.26B | · | $5.34B | |
| Net Income TTM | $1.25B | $1.36B | · | $1.37B | $4.15B | $4.18B | · | $4.16B | $1.47B | $1.41B | · | $1.38B | $1.40B | · | · | · | |
| Market Cap | $52.16B | $46.21B | · | $45.16B | $45.98B | $42.49B | · | $38.92B | $55.63B | $57.57B | · | $42.02B | $57.34B | $50.13B | · | $51.18B | |
| Enterprise Value | $48.51B | $43.13B | · | $41.92B | $42.52B | $39.19B | · | $35.07B | $54.24B | $56.46B | · | $40.75B | $56.43B | $49.48B | · | $50.04B | |
| P/E | 42.3 | 34.4 | · | 33.5 | 11.3 | 10.4 | · | 9.5 | 38.0 | 41.2 | · | 30.9 | 41.7 | 35.2 | · | 35.5 | |
| P/S | 8.1 | 7.5 | · | 7.7 | 8.1 | 7.7 | · | 7.3 | 10.7 | 11.2 | · | 8.3 | 11.0 | 9.5 | · | 9.6 | |
| P/B | 4.9 | 4.5 | · | 4.4 | 4.4 | 4.2 | · | 4.1 | 7.5 | 8.1 | · | 6.3 | 9.0 | 8.4 | · | 8.2 | |
| P / Tangible Book | 7.2 | 6.3 | · | 6.2 | 6.1 | 5.9 | · | 5.6 | 9.5 | 10.6 | · | 8.5 | 12.3 | 11.9 | · | 10.7 | |
| P / Cash Flow | · | 1054.9 | · | · | · | 151.5 | · | · | · | -1076.0 | · | · | · | 159.6 | · | · | |
| P / FCF | · | -2189.9 | · | · | · | 189.3 | · | · | · | -484.6 | · | · | · | 198.5 | · | · | |
| EV / EBITDA | 94.5 | 83.2 | · | 136.5 | 103.4 | 90.8 | · | 100.0 | 147.0 | 132.5 | · | 97.4 | 172.5 | 116.8 | · | 124.4 | |
| EV / FCF | · | -2044.2 | · | · | · | 174.6 | · | · | · | -475.3 | · | · | · | 195.9 | · | · | |
| EV / Revenue | 7.5 | 7.0 | · | 7.1 | 7.5 | 7.1 | · | 6.6 | 10.4 | 11.0 | · | 8.0 | 10.9 | 9.4 | · | 9.4 | |
| Earnings Yield | 2.4% | 2.9% | · | 3.0% | 8.9% | 9.7% | · | 10.5% | 2.6% | 2.4% | · | 3.2% | 2.4% | 2.8% | · | 2.8% |
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
Gewinn- und Verlustrechnung
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Umsatz | $6.07B | $5.44B | $5.01B | $4.46B | $5.23B |
| Bruttogewinnmarge % | 78.0% | 79.5% | 77.0% | 79.9% | 76.1% |
| Betriebsgewinnmarge % | 20.8% | 25.4% | 25.6% | 32.5% | 32.3% |
| Nettoergebnis | $1.07B | $4.17B | $1.40B | $1.52B | $1.50B |
| Verwässerte EPS | $1.83 | $6.97 | $2.30 | $2.44 | $2.38 |
Bilanz
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 |
| Liquiditätsgrad | 3.7 | 4.2 | 3.4 | 3.0 | 3.1 |
| Quick Ratio | 2.7 | 3.0 | 2.0 | 1.8 | 2.0 |
Cashflow
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Freier Cashflow | $1.33B | $290M | $643M | $974M | $1.41B |
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
📊
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das ➕ neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Institutionelle Eigentümer (13F) 1.442 Einreicher · $30.2B gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 152 (+6 vs. Vorquartal) | 97 (-10 vs. Vorquartal) | 459 (+11 vs. Vorquartal) | 452 (+4 vs. Vorquartal) | +26.4M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | $3.402.739.018 | 37.615.952 | 11,25% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $2.389.175.425 | 26.411.402 | 7,90% | Aktien |
| STATE STREET CORP | $2.381.082.692 | 26.321.940 | 7,87% | Aktien |
| WELLINGTON MANAGEMENT GROUP LLP | $1.430.999.585 | 15.819.142 | 4,73% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $1.219.437.867 | 13.541.730 | 4,03% | Aktien |
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | $1.135.640.991 | 12.554.068 | 3,75% | Aktien |
| Ninety One UK Ltd | $1.116.050.276 | 12.337.502 | 3,69% | Aktien |
| Aristotle Capital Management, LLC | $783.906.442 | 8.665.712 | 2,59% | Aktien |
| NORGES BANK | $757.492.410 | 8.373.783 | 2,50% | Aktien |
| ALLIANCEBERNSTEIN L.P. | $693.526.113 | 8.660.416 | 2,29% | Aktien |
| FMR LLC | $607.177.379 | 6.712.109 | 2,01% | Aktien |
| Artisan Partners Limited Partnership | $599.361.052 | 6.625.703 | 1,98% | Aktien |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $513.572.538 | 5.677.344 | 1,70% | Aktien |
| WELLCOME TRUST LTD (THE) as trustee of the WELLCOME TRUST | $434.208.000 | 4.800.000 | 1,44% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $334.052.859 | 3.692.824 | 1,10% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $324.280.556 | 3.584.795 | 1,07% | Aktien |
| CITADEL ADVISORS LLC | $308.338.066 | 3.408.557 | 1,02% | Aktien |
| PRIMECAP MANAGEMENT CO/CA/ | $308.314.004 | 3.408.291 | 1,02% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $298.865.427 | 3.303.843 | 0,99% | Aktien |
| BROWN ADVISORY INC | $295.062.880 | 3.261.805 | 0,98% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $292.399.738 | 3.232.365 | 0,97% | Aktien |
| Holocene Advisors, LP | $283.979.721 | 3.139.285 | 0,94% | Aktien |
| NEUBERGER BERMAN GROUP LLC | $255.069.412 | 2.818.763 | 0,84% | Aktien |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $250.776.107 | 2.772.232 | 0,83% | Aktien |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $238.277.000 | 2.634.054 | 0,79% | Aktien |
| Mirova US LLC | $229.802.865 | 2.540.381 | 0,76% | Aktien |
| BANK OF AMERICA CORP /DE/ | $170.884.489 | 1.889.061 | 0,56% | Aktien |
| BlackRock, Inc. | $168.018.323 | 1.857.377 | 0,56% | Aktien |
| Assenagon Asset Management S.A. | $163.997.286 | 1.812.926 | 0,54% | Aktien |
| Point72 Asset Management, L.P. | $160.486.895 | 1.774.120 | 0,53% | Aktien |
| RAYMOND JAMES FINANCIAL INC | $152.806.000 | 1.689.211 | 0,51% | Aktien |
| Swiss National Bank | $147.097.006 | 1.626.100 | 0,49% | Aktien |
| Woodline Partners LP | $141.123.209 | 1.560.062 | 0,47% | Aktien |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $140.351.128 | 1.551.434 | 0,46% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $137.670.984 | 1.521.899 | 0,46% | Aktien |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $131.472.173 | 1.453.357 | 0,43% | Aktien |
| Mitsubishi UFJ Asset Management Co., Ltd. | $126.120.870 | 1.394.217 | 0,42% | Aktien |
| Legal & General Group Plc | $121.108.845 | 1.338.811 | 0,40% | Aktien |
| ROYAL BANK OF CANADA | $119.193.000 | 1.317.637 | 0,39% | Aktien |
| Sumitomo Mitsui Trust Group, Inc. | $113.885.341 | 1.258.958 | 0,38% | Aktien |
| Quantinno Capital Management LP | $113.292.795 | 1.252.407 | 0,37% | Aktien |
| Vanguard Global Advisers, LLC | $112.247.472 | 1.240.852 | 0,37% | Aktien |
| VANGUARD GROUP INC | $107.656.172 | 1.262.829 | 0,36% | Aktien |
| SEB Asset Management AB | $106.981.085 | 1.182.636 | 0,35% | Aktien |
| Liontrust Investment Partners LLP | $106.083.480 | 1.244.381 | 0,35% | Aktien |
| VANGUARD ASSET MANAGEMENT, Ltd | $100.522.409 | 1.111.236 | 0,33% | Aktien |
| Polar Capital Holdings Plc | $99.945.636 | 1.104.860 | 0,33% | Aktien |
| RHUMBLINE ADVISERS | $99.213.696 | 1.096.770 | 0,33% | Aktien |
| BNP PARIBAS FINANCIAL MARKETS | $92.822.996 | 1.026.122 | 0,31% | Aktien |
| PARNASSUS INVESTMENTS, LLC | $91.873.890 | 1.015.630 | 0,30% | Aktien |
| Bank of New York Mellon Corp | $91.654.072 | 1.013.200 | 0,30% | Aktien |
| National Pension Service | $90.349.187 | 998.775 | 0,30% | Aktien |
| California Public Employees Retirement System | $89.091.250 | 984.869 | 0,29% | Aktien |
| Caisse de depot et placement du Quebec | $87.523.397 | 967.537 | 0,29% | Aktien |
| ABN AMRO Bank N.V. | $83.573.385 | 924.314 | 0,28% | Aktien |
| GOLDMAN SACHS GROUP INC | $82.454.109 | 911.498 | 0,27% | Aktien |
| Empower Advisory Group, LLC | $80.384.543 | 888.620 | 0,27% | Aktien |
| Meridiem Capital Partners LP | $77.697.994 | 858.921 | 0,26% | Aktien |
| Man Group plc | $76.372.212 | 844.265 | 0,25% | Aktien |
| ORBIMED ADVISORS LLC | $75.525.054 | 834.900 | 0,25% | Aktien |
| Alyeska Investment Group, L.P. | $73.531.316 | 812.860 | 0,24% | Aktien |
| Nantahala Capital Management, LLC | $72.368.000 | 800.000 | 0,24% | Verkaufsoption |
| CANADA PENSION PLAN INVESTMENT BOARD | $72.254.020 | 798.740 | 0,24% | Aktien |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $69.805.736 | 871.700 | 0,23% | Aktien |
| ENVESTNET ASSET MANAGEMENT INC | $66.940.606 | 740.002 | 0,22% | Aktien |
| Bellevue Group AG | $66.871.108 | 739.234 | 0,22% | Aktien |
| Birch Hill Investment Advisors LLC | $66.522.203 | 735.377 | 0,22% | Aktien |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $64.772.074 | 716.030 | 0,21% | Aktien |
| TD Asset Management Inc | $61.560.472 | 680.527 | 0,20% | Aktien |
| PRINCIPAL FINANCIAL GROUP INC | $61.491.904 | 679.769 | 0,20% | Aktien |
| UBS Group AG | $60.908.889 | 673.324 | 0,20% | Aktien |
| Candriam S.C.A. | $59.988.129 | 663.784 | 0,20% | Aktien |
| VIRGINIA RETIREMENT SYSTEMS ET Al | $57.604.363 | 675.711 | 0,19% | Aktien |
| Integral Health Asset Management, LLC | $56.537.500 | 625.000 | 0,19% | Aktien |
| Ninety One North America, Inc. | $55.768.413 | 616.498 | 0,18% | Aktien |
| Robeco Institutional Asset Management B.V. | $55.270.246 | 610.991 | 0,18% | Aktien |
| Seilern Investment Management Ltd | $54.296.896 | 600.231 | 0,18% | Aktien |
| Nan Shan Life Insurance Co., Ltd. | $49.953.912 | 552.221 | 0,17% | Aktien |
| PFA Pension, Forsikringsaktieselskab | $49.175.025 | 543.611 | 0,16% | Aktien |
| BARCLAYS PLC | $49.135.520 | 543.174 | 0,16% | Aktien |
| Triodos Investment Management BV | $44.629.165 | 493.358 | 0,15% | Aktien |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | $44.266.149 | 489.345 | 0,15% | Aktien |
| Mitsubishi UFJ Trust & Banking Corp | $43.182.890 | 477.370 | 0,14% | Aktien |
| APG Asset Management N.V. | $42.840.046 | 541.444 | 0,14% | Aktien |
| United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund | $42.480.287 | 469.603 | 0,14% | Aktien |
| Zurcher Kantonalbank (Zurich Cantonalbank) | $42.097.461 | 465.371 | 0,14% | Aktien |
| AVIVA PLC | $41.577.497 | 459.623 | 0,14% | Aktien |
| Balyasny Asset Management L.P. | $41.248.584 | 455.987 | 0,14% | Aktien |
| Korea Investment CORP | $40.486.097 | 447.558 | 0,13% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $39.585.296 | 437.600 | 0,13% | Kaufoption |
| NORDEA INVESTMENT MANAGEMENT AB | $37.761.927 | 418.322 | 0,12% | Aktien |
| STOREBRAND ASSET MANAGEMENT AS | $37.671.343 | 416.442 | 0,12% | Aktien |
| Qube Research & Technologies Ltd | $37.490.061 | 414.438 | 0,12% | Aktien |
| OFI INVEST ASSET MANAGEMENT | $36.480.086 | 458.427 | 0,12% | Aktien |
| Fisher Funds Management LTD | $35.971.057 | 397.646 | 0,12% | Aktien |
| LPL Financial LLC | $34.985.891 | 386.755 | 0,12% | Aktien |
| ABN AMRO INVESTMENT SOLUTIONS | $33.668.217 | 372.189 | 0,11% | Aktien |
| AMERIPRISE FINANCIAL INC | $32.517.021 | 359.463 | 0,11% | Aktien |
| BLAIR WILLIAM & CO/IL | $32.206.687 | 356.032 | 0,11% | Aktien |
| Champlain Investment Partners, LLC | $31.357.054 | 346.640 | 0,10% | Aktien |
Unternehmensinsider 48 Insider · 18 Führungskräfte · 8 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Bernard J Zovighian | CEO | 27. Juli 2026 S | 8.916 | 0 | 8 | $-6.996.971 |
| Theodora Mistras | CVP, Chief Financial Officer | 9. Juli 2026 A | 99.920 | 0 | 0 | $0 |
| Thomas M Abate | CVP, CFO | 14. Mai 2013 A | 43.047 | 0 | 0 | $0 |
| Wayne Markowitz | CVP, JAPAC | 30. Juli 2026 S | 21.534 | 0 | 4 | $-928.942 |
| Annette Bruls | CVP, EMEACLA | 11. Juli 2026 F | 20.628 | 0 | 0 | $0 |
| Andrew M. Dahl | SVP, Corporate Controller | 29. Mai 2026 S | 15.334 | 0 | 1 | $-48.893 |
| Carlyn D Solomon | CVP, Critical Care & Vascular | 28. Oktober 2014 M | 31.154 | 0 | 0 | $0 |
| Christine Z Mccauley | CVP, Human Resources | 13. Mai 2013 F | 4.035 | 0 | 0 | $0 |
| Paul C Redmond | CVP, Global Operations | 13. Mai 2013 S | 12.534 | 0 | 0 | $0 |
| Bruce P Garren | CVP, Public Affairs/Special Co | 13. Mai 2013 F | 56.071 | 0 | 0 | $0 |
| John H Kehl JR | CVP, Strategy & Corp Dev | 7. Mai 2013 F | 101.767 | 0 | 0 | $0 |
| Robert C Reindl | CVP, H.R. and Communications | 27. Juli 2012 M | 1.124 | 0 | 0 | $0 |
| Aimee S Weisner | CVP, General Counsel | 9. Mai 2012 A | 1.675 | 0 | 0 | $0 |
| Corinne H Nevinny | CVP & Pres., Global Ops | 13. Mai 2010 A | 16.687 | 0 | 0 | $0 |
| Anita Bessler | CVP | 31. August 2007 S | 29.410 | 0 | 0 | $0 |
| John Alexander Martin | CVP, North America | 10. Mai 2007 A | 15.300 | 0 | 0 | $0 |
| Stuart L Foster | CVP, Critical Care / Vascular | 10. Mai 2007 A | 24.604 | 0 | 0 | $0 |
| Randel William Woodgrift | Corp VP, Manufacturing Ops | 4. August 2005 M | 3.349 | 0 | 0 | $0 |
| John T Cardis | Direktor | 10. August 2016 S | 91.458 | 0 | 0 | $0 |
| Barbara J Mcneil | Direktor | 4. Februar 2016 S | 46.454 | 0 | 0 | $0 |
| Robert Alexander Ingram | Direktor | 15. Mai 2015 A | 32.367 | 0 | 0 | $0 |
| Michael R Bowlin | Direktor | 14. November 2014 M | 81.751 | 0 | 0 | $0 |
| David E I Pyott | Direktor | 9. Mai 2014 A | 53.582 | 0 | 0 | $0 |
| NEAL PHILIP M | Direktor | 12. August 2008 M | 27.333 | 0 | 0 | $0 |
| Vernon R Loucks JR | Direktor | 9. Mai 2008 A | 24.133 | 0 | 0 | $0 |
| Daniel J. Lippis | — | 11. August 2026 M | 40.034 | 0 | 12 | $-817.452 |
| Donald E Bobo JR | — | 27. Mai 2026 S | 98.611 | 0 | 12 | $-11.153.294 |
| Daveen Chopra | — | 22. Mai 2026 S | 44.324 | 0 | 3 | $-500.535 |
| Scott B. Ullem | — | 11. Mai 2026 M | 46.740 | 0 | 7 | $-3.875.008 |
| Leslie C. Davis | — | 8. Mai 2026 A | 9.834 | 0 | 0 | $0 |
| Ramona Sequeira | — | 8. Mai 2026 A | 6.779 | 0 | 0 | $0 |
| David T Feinberg | — | 8. Mai 2026 A | 9.087 | 0 | 0 | $0 |
| Kieran Gallahue | — | 8. Mai 2026 A | 4.315 | 0 | 0 | $0 |
| Nicholas J Valeriani | — | 8. Mai 2026 A | 84.423 | 0 | 0 | $0 |
| Heisz Leslie Stone | — | 8. Mai 2026 A | 34.199 | 0 | 1 | $-218.117 |
| Steven R Loranger | — | 8. Mai 2026 A | 8.997 | 0 | 0 | $0 |
| Paul A Laviolette | — | 8. Mai 2026 A | 17.552 | 0 | 0 | $0 |
| Larry L Wood | — | 18. August 2025 M | 206.900 | 0 | 0 | $0 |
| Catherine M. Szyman | — | 3. September 2024 F | 81.287 | 0 | 0 | $0 |
| Jean-Luc M Lemercier | — | 7. Juli 2024 F | 184.686 | 0 | 0 | $0 |
| Robert W.A. Sellers | — | 11. Mai 2024 F | 17.081 | 0 | 0 | $0 |
| Michael A Mussallem | — | 2. Mai 2024 M | 4.486 | 0 | 0 | $0 |
| Martha H. Marsh | — | 12. Mai 2023 A | 31.880 | 0 | 0 | $0 |
| Huimin Wang | — | 8. Juli 2022 M | 99.381 | 0 | 0 | $0 |
| William J Link PHD | — | 8. Mai 2020 A | 11.349 | 0 | 0 | $0 |
| Wesley W Von Schack | — | 1. August 2019 S | 8.000 | 0 | 0 | $0 |
| Patrick B Verguet | — | 31. Mai 2017 M | 129.137 | 0 | 0 | $0 |
| Randall J Nelson | — | 30. September 2003 A | — | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
Aktivisten & 5%+-Eigentümer 1 Beteiligung
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Nicht offengelegter meldender Beteiligter | 5. April 2001 | — | Erste Einreichung | Vorstandskampagne | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF-Besitz Gehalten von 180 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| IHI · iShares Trust | 4,29% | 1.607.851 SH | 8. August 2026 | Täglich |
| GDOC · Goldman Sachs ETF Trust | 2,98% | 6.939 NS | 31. Mai 2026 | N-PORT |
| FMED · Fidelity Covington Trust | 2,11% | 10.000 NS | 31. Mai 2026 | N-PORT |
| ANEW · ProShares Trust | 2,02% | 1.801 NS | 31. Mai 2026 | N-PORT |
| JDOC · J.P. Morgan Exchange-Traded Fund Tr… | 1,83% | 2.435 NS | 30. April 2026 | N-PORT |
| PJBF · PGIM ETF Trust | 1,75% | 2.374 NS | 29. Mai 2026 | N-PORT |
| HRTS · Tema ETF Trust | 1,75% | 10.488 NS | 31. Mai 2026 | N-PORT |
| RSPH · Invesco Exchange-Traded Fund Trust | 1,58% | 137.940 SH | 8. August 2026 | Täglich |
| VOT · VANGUARD INDEX FUNDS | 1,14% | 4.411.246 SH | 8. August 2026 | Täglich |
| ALTL · Pacer Funds Trust | 0,94% | 10.780 NS | 30. April 2026 | N-PORT |
| CVAR · ETF Opportunities Trust | 0,93% | 4.325 NS | 30. April 2026 | N-PORT |
| SDG · iShares Trust | 0,90% | 17.447 SH | 8. August 2026 | Täglich |
| FFND · Northern Lights Fund Trust II | 0,88% | 10.459 NS | 31. Mai 2026 | N-PORT |
| IYH · iShares Trust | 0,83% | 341.366 SH | 8. August 2026 | Täglich |
| BKDV · BNY Mellon ETF Trust II | 0,81% | 134.666 NS | 30. April 2026 | N-PORT |
| NULV · Nushares ETF Trust | 0,79% | 197.378 NS | 30. April 2026 | N-PORT |
| JOET · Virtus ETF Trust II | 0,79% | 22.410 NS | 30. April 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0,78% | 267.514 NS | 30. April 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0,77% | 1.733.147 SH | 8. August 2026 | Täglich |
| NULC · Nushares ETF Trust | 0,75% | 5.090 NS | 30. April 2026 | N-PORT |
| RXL · ProShares Trust | 0,73% | 6.052 NS | 31. Mai 2026 | N-PORT |
| CURE · Direxion Shares ETF Trust | 0,70% | 11.571 NS | 30. April 2026 | N-PORT |
| IMCG · iShares Trust | 0,66% | 301.692 SH | 8. August 2026 | Täglich |
| IXJ · iShares Trust | 0,65% | 302.050 SH | 8. August 2026 | Täglich |
| TEC · Harbor ETF Trust | 0,61% | 491 NS | 30. April 2026 | N-PORT |
| FWD · AB Active ETFs, Inc. | 0,56% | 187.544 NS | 31. Mai 2026 | N-PORT |
| HUSV · First Trust Exchange-Traded Fund III | 0,56% | 4.857 NS | 30. April 2026 | N-PORT |
| BRNY · EA Series Trust | 0,54% | 35.555 NS | 30. April 2026 | N-PORT |
| AVMC · AMERICAN CENTURY ETF TRUST | 0,53% | 24.654 NS | 31. Mai 2026 | N-PORT |
| SUSA · iShares Trust | 0,51% | 237.552 SH | 8. August 2026 | Täglich |
| VO · VANGUARD INDEX FUNDS | 0,50% | 12.477.902 SH | 8. August 2026 | Täglich |
| IWS · iShares Trust | 0,49% | 860.071 SH | 8. August 2026 | Täglich |
| FXH · First Trust Exchange-Traded AlphaDE… | 0,42% | 44.305 NS | 30. April 2026 | N-PORT |
| HELO · J.P. Morgan Exchange-Traded Fund Tr… | 0,40% | 193.493 NS | 30. April 2026 | N-PORT |
| JOYT · J.P. Morgan Exchange-Traded Fund Tr… | 0,37% | 3.768 NS | 30. April 2026 | N-PORT |
| IWR · iShares Trust | 0,36% | 2.320.860 SH | 8. August 2026 | Täglich |
| IMCB · iShares Trust | 0,34% | 63.843 SH | 8. August 2026 | Täglich |
| JGLO · J.P. Morgan Exchange-Traded Fund Tr… | 0,34% | 286.558 NS | 30. April 2026 | N-PORT |
| EVUS · iShares Trust | 0,31% | 12.935 SH | 8. August 2026 | Täglich |
| NBCR · Neuberger Berman ETF Trust | 0,30% | 30.404 NS | 31. Mai 2026 | N-PORT |
| OMFL · Invesco Exchange-Traded Self-Indexe… | 0,29% | 156.342 SH | 8. August 2026 | Täglich |
| XOEF · iShares Trust | 0,28% | 720 SH | 8. August 2026 | Täglich |
| ESUM · Strategy Shares | 0,27% | 5.033 NS | 30. April 2026 | N-PORT |
| DFLV · Dimensional ETF Trust | 0,27% | 189.108 NS | 30. April 2026 | N-PORT |
| WINN · Harbor ETF Trust | 0,24% | 31.226 NS | 30. April 2026 | N-PORT |
| DEUS · DBX ETF Trust | 0,24% | 7.428 NS | 29. Mai 2026 | N-PORT |
| HEQQ · J.P. Morgan Exchange-Traded Fund Tr… | 0,23% | 887 NS | 30. April 2026 | N-PORT |
| FFLG · FIDELITY COVINGTON TRUST | 0,22% | 15.544 NS | 30. April 2026 | N-PORT |
| CAPE · DoubleLine ETF Trust | 0,22% | 7.122 NS | 31. März 2026 | N-PORT |
| GSEW · Goldman Sachs ETF Trust | 0,21% | 42.168 NS | 31. Mai 2026 | N-PORT |